Pulmonary multifunctional nano-oncological modules for lung cancer treatment and prevention

Insights

Lung cancer treatment faces significant hurdles due to the lung

Area of Science:

  • Oncology and Nanotechnology
  • Pulmonary Drug Delivery

Background:

  • Lung cancer mortality remains high, despite the lung being an accessible organ.
  • Conventional lung cancer treatments face challenges from the complex lung environment.
  • Extracellular and intracellular barriers impede therapeutic efficacy in lung cancer.

Purpose of the Study:

  • To review the challenges in lung cancer treatment.
  • To explore advanced nano-oncological modules for pulmonary drug delivery.
  • To highlight strategies overcoming lung-specific therapeutic impediments.

Main Methods:

  • Review of current literature on lung cancer treatment challenges.
  • Analysis of multifunctional nano-oncological modules for pulmonary delivery.
  • Examination of strategies to overcome extracellular and intracellular barriers.

Main Results:

  • The lung's complex extracellular environment (mucus, fluid, cilia) hinders drug delivery.
  • Intracellular barriers (enzymatic degradation, translocation, endosomal escape) limit treatment effectiveness.
  • Multifunctional nano-oncological modules offer promising solutions for pulmonary drug delivery.

Conclusions:

  • Overcoming lung-specific barriers is crucial for effective lung cancer therapy.
  • Nanotechnology-based pulmonary delivery systems show potential to enhance treatment outcomes.
  • Advanced nano-modules can address both extracellular and intracellular challenges in lung cancer.